{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:56:22Z","timestamp":1771570582017,"version":"3.50.1"},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1333,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>:<\/jats:bold>Several lines of evidence support a dual\u2010deficit model of stimulant withdrawal in which decreases in synaptic dopamine (DA) and serotonin (5\u2010HT) contribute to withdrawal symptoms, drug craving, and relapse. According to the dual\u2010deficit model, DA dysfunction during withdrawal underlies anhedonia and psychomotor disturbances, whereas 5\u2010HT dysfunction gives rise to depressed mood, obsessive thoughts, and lack of impulse control. The model suggests that medications capable of normalizing stimulant\u2010induced DA and 5\u2010HT deficits should be effective treatment adjuncts. Furthermore, the model may explain why medications targeting only one neurotransmitter system (i.e., DA) have failed to treat cocaine dependence. Amphetamine\u2010type appetite suppressants are logical choices for neurochemical normalization therapy of stimulant dependence, yet few clinical studies have tested anorectics in this regard. The chief purpose of the present work is to profile the activity of various anorectic agents at DA, 5\u2010HT, and NE transporters, in order to identify possible medications for stimulant dependence. Compounds were tested<jats:italic>in vitro<\/jats:italic>for their ability to stimulate release and inhibit uptake of [<jats:sup>3<\/jats:sup>H]DA, [<jats:sup>3<\/jats:sup>H]NE, and [<jats:sup>3<\/jats:sup>H]5\u2010HT. Selected compounds were tested<jats:italic>in vivo<\/jats:italic>for their ability to elevate extracellular levels of DA and 5\u2010HT in rat nucleus accumbens. The results show that clinically available appetite suppressants display a wide range of activities at monoamine transporters. However, no single medication possesses equal potency at DA and 5\u2010HT transporters, suggesting that none of the anorectics is ideally suited for treatment of stimulant addictions. Future efforts should focus on developing new medications that possess the desired therapeutic activity but lack the adverse effects associated with older amphetamine\u2010type anorectics.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb04155.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T00:53:08Z","timestamp":1279673588000},"page":"109-126","source":"Crossref","is-referenced-by-count":37,"title":["Appetite Suppressants as Agonist Substitution Therapies for Stimulant Dependence"],"prefix":"10.1111","volume":"965","author":[{"given":"RICHARD B.","family":"ROTHMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BRUCE E.","family":"BLOUGH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL H.","family":"BAUMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.14.4.390"},{"key":"e_1_2_4_3_2","first-page":"7","article-title":"Cocaine's history, especially the American experience","volume":"166","author":"Musto D.F.","year":"1992","journal-title":"Ciba Found. Symp."},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb04661.x"},{"key":"e_1_2_4_5_2","first-page":"882","article-title":"Increasing morbidity and mortality associated with abuse of methamphetamine\u2014United States, 1991\u20101994","volume":"44","author":"Anonymous","year":"1995","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_4_6_2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/jnp.12.4.480","article-title":"Psychiatric comorbidity of methamphetamine dependence in a forensic sample","volume":"12","author":"Kalechstein A.D.","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"e_1_2_4_7_2","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse","volume":"264","author":"Regier D.A.","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19940801-07"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1300\/J082v41n02_02"},{"key":"e_1_2_4_10_2","first-page":"547","article-title":"Drug abuse, psychiatric disorders, and AIDS","volume":"152","author":"Batki S.L.","year":"1990","journal-title":"Dual and triple diagnosis. West. J. Med."},{"key":"e_1_2_4_11_2","first-page":"152","article-title":"Research and development costs for new drugs by therapeutic category","volume":"7","author":"DiMasi J.A.","year":"1995","journal-title":"A study of the US pharmaceutical industry. Pharmacoeconomics"},{"key":"e_1_2_4_12_2","first-page":"4","article-title":"Overview: medications development for the treatment of drug abuse","volume":"149","author":"Vocci F.","year":"1995","journal-title":"NIDA Res. Monogr."},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60914-X"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511023331807"},{"key":"e_1_2_4_15_2","first-page":"232","article-title":"Opiates, opioids and addiction","volume":"1","author":"Kreek M.J.","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1994.10472259"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199712000-00008"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00010"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(99)00076-8"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000439"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199504000-00009"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(85)90043-1"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1300\/J251v06n02_02"},{"key":"e_1_2_4_24_2","unstructured":"Gorelick D.A. 1997. Pharmacologic therapies for cocaine and other stimulant addiction.InPrinciples of Addiction Medicine. A.W. Graham & T.K. Schultz Eds. American Society of Addiction Medicine. Chevy Chase MD."},{"key":"e_1_2_4_25_2","first-page":"137","article-title":"Variability in treatment\u2010seeking cocaine abusers: implications for clincal pharmacotherapy trials","volume":"175","author":"Carroll K.M.","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(96)10024-9"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb25970.x"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890110204"},{"key":"e_1_2_4_29_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0022-3565(25)10596-X","article-title":"Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine","volume":"274","author":"Parsons L.H.","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00280-X"},{"key":"e_1_2_4_31_2","unstructured":"Baumann M.H. & R.B. Rothman. 1998. Serotonergic dysfunction during cocaine withdrawal: implications for cocaine\u2010induced depression.InDrug Abuse Handbook. S.B. Karch Ed.: 463\u2010484. CRC Press. Boca Raton."},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1994.1006"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890090109"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90451-Z"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90706-A"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb08222.x"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00123-1"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#"},{"key":"e_1_2_4_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051060"},{"key":"e_1_2_4_40_2","first-page":"17","article-title":"Postcocaine anhedonia","volume":"4","author":"Markou A.","year":"1991","journal-title":"An animal model of cocaine withdrawal. Neuropsychopharmacology"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(96)00110-3"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(98)00068-8"},{"key":"e_1_2_4_43_2","unstructured":"Hitzig P. 1993. Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive behaviors. Maryland Med. J. Feb. 153\u2010157."},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(94)90086-8"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426841"},{"key":"e_1_2_4_46_2","first-page":"351","article-title":"Anorectics: effects on food intake and self\u2010administration in rhesus monkeys","volume":"7","author":"Corwin R.L.","year":"1987","journal-title":"Alcohol Drug Res."},{"key":"e_1_2_4_47_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-5347(25)00192-2","article-title":"Amphetamine\u2010like effects of anorectics and related compounds in pigeons","volume":"241","author":"Evans S.M.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181948"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050296"},{"key":"e_1_2_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)01003-8"},{"key":"e_1_2_4_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.8.869"},{"key":"e_1_2_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00113-R"},{"key":"e_1_2_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00657-8"},{"key":"e_1_2_4_54_2","doi-asserted-by":"publisher","DOI":"10.1006\/appe.1996.0059"},{"key":"e_1_2_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1995.tb00222.x"},{"key":"e_1_2_4_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532386"},{"key":"e_1_2_4_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2299(200010)51:2<52::AID-DDR2>3.0.CO;2-H"},{"key":"e_1_2_4_58_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-3565(24)37989-3","article-title":"Effects of phentermine on responding maintained under multiple fixed\u2010ratio schedules of food\u2010presentation and cocaine\u2010delivery in the rhesus monkey","volume":"288","author":"Wojnicki F.H.E.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199704140-00006"},{"key":"e_1_2_4_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050836"},{"key":"e_1_2_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00158-7"},{"key":"e_1_2_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2728(93)90109-S"},{"key":"e_1_2_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00068-4"},{"key":"e_1_2_4_64_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-3565(25)24002-2","article-title":"GBR12909 attenuates cocaine\u2010induced activation of mesolimbic dopamine neurons in the rat","volume":"271","author":"Baumann M.H.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_65_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995"},{"key":"e_1_2_4_66_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-3565(25)10706-4","article-title":"Pharmacokinetic and pharmacodynamic analysis of the actions of D\u2010amphetamine and D\u2010methamphetamine on the dopamine terminal","volume":"274","author":"Melega W.P.","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(01)00013-4"},{"key":"e_1_2_4_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K"},{"key":"e_1_2_4_69_2","unstructured":"Paxinos G. & C. Watson. 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press. New York."},{"key":"e_1_2_4_70_2","first-page":"322","article-title":"Studies of the biogenic amine transporters","volume":"28","author":"Rothman R.B.","year":"1998","journal-title":"VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate. Synapse"},{"key":"e_1_2_4_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"e_1_2_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(74)90272-6"},{"key":"e_1_2_4_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701325"},{"key":"e_1_2_4_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005260"},{"key":"e_1_2_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(00)00210-8"},{"key":"e_1_2_4_76_2","first-page":"1307","article-title":"Simultaneous determination of amfepramon and its two major metabolites in biological fluids by gas liquid chromatography","volume":"36","author":"Dangor C.M.","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_4_77_2","first-page":"40","article-title":"Bioavailability in man of phendimetrazine from various dosage forms","volume":"28","author":"Beckett A.H.","year":"1976","journal-title":"J. Pharm. Pharmacol."},{"key":"e_1_2_4_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"e_1_2_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-2806(99)90013-0"},{"key":"e_1_2_4_80_2","doi-asserted-by":"crossref","unstructured":"Gurtner H.P. 1990. Aminorex pulmonary hypertension.InThe Pulmonary Circulation: Normal and Abnormal. A.P. Fishman Ed.: 397\u2010411. Univ. of Pennsylvania Press. Philadelphia.","DOI":"10.9783\/9781512801736-031"},{"issue":"1","key":"e_1_2_4_81_2","first-page":"80","article-title":"Assessment of reinforcing properties of amphetamine analogues in self\u2010administering rats","volume":"51","author":"Gotestam K.G.","year":"1975","journal-title":"Postgrad. Med. J."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb04155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb04155.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T05:17:16Z","timestamp":1740287836000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb04155.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb04155.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04155.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}